Tag

Phenylephrine

All articles tagged with #phenylephrine

health1 year ago

Pharmacist Reveals Top 'Scam' Cold and Flu Medications to Avoid

As cold season arrives, many over-the-counter cold medicines, including those containing phenylephrine, are found to be ineffective. Effective alternatives include pain relievers like Tylenol and ibuprofen, pseudoephedrine for congestion, and certain nasal sprays. Preventive measures such as vaccination for flu and COVID-19, handwashing, and air ventilation are recommended. Non-pharmaceutical remedies like honey, zinc, and vitamin C may also help, while rest and hydration remain crucial. Consult a healthcare provider if symptoms persist or worsen.

health1 year ago

FDA Moves to Ban Ineffective Phenylephrine in Cold Medicines

The FDA has proposed removing oral phenylephrine from cold, cough, and allergy medications, as it is ineffective as a decongestant. This decision follows a unanimous advisory committee conclusion and years of scientific evidence showing phenylephrine's ineffectiveness compared to a placebo. The proposal, open for public comment, could significantly impact the $1.76 billion market of over-the-counter decongestants, affecting popular brands like Sudafed and Tylenol. The ruling does not apply to nasal sprays or eye drops, where phenylephrine is more effective.

health1 year ago

FDA Moves to Ban Ineffective Decongestant from Cold Medicines

The FDA has proposed removing oral phenylephrine, a common ingredient in over-the-counter cold and cough medicines, citing its ineffectiveness as a nasal decongestant. This proposal follows a unanimous vote by an expert panel against its efficacy. The FDA is seeking public comments on the proposal, and companies can continue selling products with oral phenylephrine for now. The Consumer Healthcare Products Association expressed disappointment with the FDA's decision, while companies like Procter & Gamble and GSK have yet to comment.

health1 year ago

FDA Targets Ineffective Decongestant for Market Removal

The FDA has proposed removing oral phenylephrine, a common ingredient in over-the-counter decongestants like Sudafed PE and DayQuil, from the market due to evidence of ineffectiveness. This proposal initiates a six-month public comment period before a final decision is made. While CVS has already stopped selling phenylephrine products, other pharmacies continue to stock them. The FDA's move follows several studies and an advisory committee's conclusion that phenylephrine is ineffective at typical oral dosages. The proposal does not affect phenylephrine used in nasal sprays.

health1 year ago

FDA Targets Ineffective Decongestant for Market Removal

The FDA is proposing to remove oral phenylephrine, a common ingredient in over-the-counter cold medicines, from the market due to its ineffectiveness as a nasal decongestant. This follows an advisory panel's conclusion that there is no scientific evidence supporting its efficacy. While phenylephrine is still effective in nasal sprays, its removal from oral medications like Tylenol Cold and Flu and Dayquil could lead to reformulations. The proposal is open for public comment, and the FDA assures that the decision is not based on safety concerns.

health1 year ago

FDA Moves to Ban Ineffective Cold Medicine Phenylephrine

The FDA plans to remove oral phenylephrine, a common ingredient in over-the-counter cold medicines, from the market due to its ineffectiveness as a nasal decongestant. This decision follows a review of data showing minimal absorption of the drug when ingested, rendering it no more effective than a placebo. The public can comment on the proposal until May 7, 2025, after which manufacturers may need to reformulate or withdraw affected products. The Consumer Healthcare Products Association opposes the move, arguing for consumer choice.

health1 year ago

FDA Moves to Ban Common Decongestant in Cold Medicines

The FDA has proposed ending the use of oral phenylephrine, a common ingredient in many over-the-counter cold and allergy medications, after determining it is ineffective as a nasal decongestant. This decision follows a unanimous conclusion by FDA advisors and could lead to the removal of products like NyQuil and Sudafed from shelves, impacting sales and requiring drugmakers to reformulate their products. The proposal is not based on safety concerns, and the final decision is pending.

health1 year ago

"FDA Ban on Ineffective Decongestants Threatens Supply Chain and Access to Remedies"

The U.S. FDA is considering removing phenylephrine, an ineffective nasal decongestant, from over-the-counter cold remedies, but this could disrupt the supply chain and leave consumers without readily available options. Despite phenylephrine's lack of effectiveness, the cold remedies containing it also include other helpful ingredients. The dilemma highlights the need for tighter regulation of over-the-counter medications to ensure their effectiveness.

health-medicine1 year ago

"Phenylephrine Ban's Impact on Access to Remedies"

The U.S. FDA is considering removing phenylephrine, an ineffective nasal decongestant, from over-the-counter cold remedies, which could disrupt supply chains and leave consumers without readily available options. Despite its lack of effectiveness, phenylephrine products remain popular due to their combination with other helpful ingredients. This dilemma highlights the need for tighter regulation of over-the-counter medications and a comparable pathway for monitoring their effectiveness, according to researchers.

health2 years ago

"House Republicans Demand Explanation from FDA on Delayed Cold Medicine Effectiveness Disclosure"

House Republicans have summoned FDA officials to explain why it took so long for the agency to declare a common decongestant ingredient, phenylephrine, ineffective despite decades of evidence. The FDA announced in September that phenylephrine, found in popular oral cold medicines, was no more effective than a placebo at relieving a stuffy nose. The ingredient is protected under the FDA's Generally Recognized as Safe and Effective (GRASE) designation, and while the vote does not require manufacturers to pull products from shelves, some stores, like CVS, have stopped selling them. The meeting between FDA officials and House members is scheduled for December 11.

health2 years ago

"Expert-Backed Cold Medicine Recommendations for Effective Relief"

The FDA has warned that popular cold medications containing phenylephrine, such as DayQuil and Advil Sinus Congestion and Pain, are ineffective when taken orally. Doctors and pharmacists are now advising patients to seek alternative options, including pseudoephedrine, which is more effective but requires a prescription due to its potential for misuse in producing methamphetamine. Some consumers and advocates are calling for phenylephrine medications to be removed from shelves entirely. In the meantime, patients can consider home remedies like honey for a sore throat, saline rinses, and topical vapor rubs, or consult their pharmacists for recommendations.

health2 years ago

Mucinex Disappears from Shelves, Shoppers Outraged

Shoppers are claiming that Mucinex, an over-the-counter (OTC) medication, is being pulled from pharmacy shelves, sparking outrage on social media. Earlier this year, the U.S. Food and Drug Administration (FDA) ruled that phenylephrine, the main ingredient in many OTC cold and cough products, is not effective as a nasal decongestant. While the FDA has not officially deemed phenylephrine "not effective" or removed it as a recognized ingredient, CVS Pharmacy has voluntarily removed some medications containing oral phenylephrine. However, the removal of Mucinex has not been confirmed, and the current social media uproar may be unfounded, as Mucinex products are still available for purchase.

health2 years ago

Unveiling the Truth Behind Cold Meds: What Really Works for Cold and Flu Symptoms

Two scientists, Randy Hatton and Leslie Hendeles, have been warning since the 1990s that phenylephrine, the main ingredient in popular cold and flu medications, is ineffective. Despite their findings, the FDA and consumer groups dismissed their concerns, allowing the phenylephrine medicine industry to profit nearly $2 billion last year. However, the FDA's recent announcement that phenylephrine is ineffective as an oral decongestant may lead to the ingredient being pulled from store shelves. CVS has already decided to remove certain cough and cold medicines containing phenylephrine, while other major chains like Walgreens and RiteAid will only do so if the FDA demands it. The scientists' research showed that phenylephrine is rapidly absorbed and eliminated before it can have any effect, rendering it essentially worthless.

health2 years ago

"FDA Discredits OTC Cold Medicines: Doctors Recommend Alternatives"

The US Food and Drug Administration (FDA) has ruled that phenylephrine, a key ingredient in some over-the-counter cold medications, is ineffective. As a result, popular products containing phenylephrine, such as Benadryl Allergy Plus Congestion, Sudafed PE, and Tylenol Cold and Flu Severe Day & Night, are being pulled from store shelves. Dr. Stuart Fischer, an internal medicine doctor, recommends alternatives such as chicken soup, diphenhydramine, Robitussin, and N-acetyl cysteine (NAC). He also suggests taking probiotics to boost immune health. The FDA ruling is not binding, but it may lead to the removal or reformulation of products containing phenylephrine. Dr. Fischer supports the ruling, citing the potential side effects of phenylephrine, including increased blood pressure.

health2 years ago

CVS Removes Phenylephrine Medications from Shelves, Rite Aid Continues to Stock Them

Rite Aid will continue to sell medications containing phenylephrine, a popular ingredient in cold and cough products, despite an advisory committee declaring it ineffective when taken orally. The decision is subject to change if the FDA decides to remove products with this ingredient. CVS, on the other hand, has already announced the removal of such products from their stores, while Walgreens is awaiting a final decision from federal regulators. The FDA has not issued a final decision yet and has not asked manufacturers or retail pharmacies to remove products with phenylephrine from shelves.